TY - JOUR
T1 - Prevention and treatment of low back pain
T2 - evidence, challenges, and promising directions
AU - Foster, Nadine E.
AU - Anema, Johannes R.
AU - Cherkin, Dan
AU - Chou, Roger
AU - Cohen, Steven P.
AU - Gross, Douglas P.
AU - Ferreira, Paulo H.
AU - Fritz, Julie M.
AU - Koes, Bart W.
AU - Peul, Wilco
AU - Turner, Judith A.
AU - Maher, Chris G.
AU - Lancet Low Back Pain Series Workin
AU - Smeets, Rob
PY - 2018/6/9
Y1 - 2018/6/9
N2 - Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.
AB - Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.
KW - MULTIDISCIPLINARY CARE PATHWAY
KW - POPULATION-BASED-INTERVENTION
KW - SPINE SURGERY REFERRALS
KW - UNITED-STATES
KW - EMERGENCY-DEPARTMENT
KW - PHYSIOTHERAPY MANAGEMENT
KW - MEDICARE POPULATION
KW - PHYSICAL-THERAPISTS
KW - CLINICAL PATHWAYS
KW - PRACTICE PATTERNS
U2 - 10.1016/S0140-6736(18)30489-6
DO - 10.1016/S0140-6736(18)30489-6
M3 - Article
SN - 0140-6736
VL - 391
SP - 2368
EP - 2383
JO - Lancet
JF - Lancet
IS - 10137
ER -